Overview

Effect of Intraoperative Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Robot-assisted Pancreaticoduodenectomy: a Randomized Controlled Study

Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
0
Participant gender:
All
Summary
To observe the effect of intraoperative dexmedetomidine on the incidence of postoperative delirium, postoperative analgesic drug requirements and pain scores in elderly patients undergoing robot-assisted pancreaticoduodenectomy.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chinese PLA General Hospital
Collaborator:
Beijing Tiantan Hospital
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- Patients over 65 years old

- Patients undergoing elective robotic-assisted pancreaticoduodenectomy.

- Written informed consent was obtained.

Exclusion Criteria:

- Patients with severe preoperative cognitive impairment (MMSE ≤ 20) who are unable to
undergo a follow-up evaluation.

- Patients with history of psychiatric or neurological disorders.

- Patients with body mass index ≤ 18 or ≥ 30

- Pregnant or lactating women

- Patients with severe bradycardia (heart rate less than 40 beats per minute)

- Patients with pathological sinus node syndrome or grade 2 or greater AV block

- Patients with severe hepatic or renal insufficiency.

- Patients with severe hypertension (systolic blood pressure ≥ 180 mmHg or diastolic
blood pressure ≥ 110 mmHg)